Home / People / Maria Letizia Patania
Portrait ofMaria Letizia Patania

Maria Letizia Patania

Partner

CMS Adonnino Ascoli & Cavasola Scamoni
Via A. Depretis 86
00184 Rome
Italy
Languages Italian, English

Maria Letizia Patania began her collaboration with the Firm in 2004.

Her work in the Rome office focuses on commercial and pharmaceutical law and commercial litigation, both in arbitration proceedings and before the judicial authorities. Throughout her career she has also developed significant experience with regards to the legal liability of legal persons.

As for the latter, Maria Letizia has assisted numerous companies in the drafting of ex L. 231/01 models and in their regular updating.
Her clients include important companies operating in the healthcare sector, in the field of fuel storage and distribution, energy services and infrastructure services. Maria Letizia is currently chairman of the Compliance Program Supervisory Boards of several important Italian energy companies.

more less

Memberships & Roles

  • Rome Bar Association
more less

Education

  • 2006 – Admitted to the Rome Bar Association
  • 2004 – Postgraduate diploma in commercial law
  • 2003 – University of Rome “LUISS Guido Carli”, Law Degree
more less

Feed

27/03/2024
Cannabis law and legislation in Italy
Medical use Growing, selling and importing medical cannabis is allowed on the condition that the authorisation of the Ministry of Health is obtained. Cultivation, sale and import are currently mainly...
14/02/2024
Recognition and enforcement of foreign judgments in Italy
1. Is there an exequatur procedure? Yes. Recognition of a foreign judgment takes place automatically as long as the requirements are met and no grounds for refusal are invoked. Execution can be sought...
18/12/2023
Digital health apps and telemedicine in Italy
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? 1.1 Is it considered a “medical device” or a “product”...
Comparable
28/10/2022
Italian reform on arbitration: new rules on provisional measures and expedited...
By Legislative Decree No. 149 of 10 October 2022 (the "Decree 149/2022"), the Italian Government has introduced significant amendments to the Italian rules governing the arbitration proceedings. The amendments...
27/10/2022
Legislative Decree No. 149 of 10 October 2022 - the new rules on Italian...
By Legislative Decree No. 149 of 10 October 2022 (the "Decree 149/2022"), the Italian Government has made significant amendments to the provisions of the Italian Code of Civil Procedure ("CCP") governing...
15/09/2022
Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? Advertising of medicines is regulated in a specific section of Legislative Decree no. 219/2006 (“Code of Medicines”)...
15/06/2022
The new Italian Sunshine Act
The Social Affairs Commission of the Italian Chamber of Deputies recently approved the final version of the so-called Sunshine Act, bearing “Provisions on the transparency of relations between manufacturing...
07/06/2022
Adverse effects of drugs and vaccines in Italy
1. Drug adverse effects: kinds of responsibility 1.1 Which are the main kinds of responsibility (contractual, in tort, criminal) of the following subjects with respect to adverse drugs reactions? A...
Comparable
10/12/2021
Law 10 November 2021, n. 175: in the Official Gazette the new provisions...
On November 27, 2021, Law No. 175/2021, setting forth "Provisions for the treatment of rare diseases and for the support of research and production of orphan drugs." was published in the Official Gazette...
01/12/2021
Law 10 November 2021, n. 175: the new provisions for the treatment of rare...
On November 27, 2021, Law No. 175/2021, setting forth "Provisions for the treatment of rare diseases and for the support of research and production of orphan drugs." was published in the Official Gazette...
23/03/2020
Covid-19 in Italy: simplified procedures for pharmaceuticals and clinical...
In the context of the COVID-19 emergency, both the Council of Ministers and the Italian Regulator (AIFA - Agenzia Italiana del Farmaco) have issued some measures mainly aimed at streamlining the authorization...
01/02/2019
Getting the Deal Through – Life Sciences 2019
Accreditation: Reproduced with permission from Law Business Research Ltd. This article was first published in Getting the Deal Through – Life Sciences 2019 (Published: January 2019). For further information...